title: Special considerations in the use of glucocorticoids in children.
abstract: GCs are used commonly for the treatment of various inflammatory and autoimmune diseases. Although potent and generally effective, they are not without risks for producing serious adverse effects, especially when used in high doses for prolonged periods of time. Thus, the clinician must balance the therapeutic effects of GCs with their risks for adverse effects; using the lowest possible effective GC doses as well as maximizing other therapeutic modalities are means by which this goal can be achieved. Early recognition and appropriate management are other methods to minimize GC-induced adverse effects. Maximization of therapy, early recognition, and appropriate management of adverse effects can minimize the potential severe complications of GC therapy.
authors.affiliation: Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO, USA.
authors.forename: J D
authors.initials: JD
authors.lastname: Spahn
authors.forename: A K
authors.initials: AK
authors.lastname: Kamada
mesh_terms: D002644:Chickenpox / Q000276:immunology; D002648:Child; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D010024:Osteoporosis / Q000139:chemically induced; D013312:Stress, Physiological / Q000503:physiopathology; D013514:Surgical Procedures, Operative
chemical_list: D005938:Glucocorticoids